- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06318182
Testicular Self-Examination Awareness in Young Men
The Effect of Training Based on the Health Belief Model on Testicular Self-Examination Awareness and Health Beliefs in Young Men
This study aims to determine the effect of education based on the health belief model on testicular self-examination awareness and health beliefs in young men.
H0 Hypothesis: Education based on the health belief model has no effect on the awareness of testicular self-examination and health beliefs about testicular self-examination of young men in the experimental and control groups.
H1a Hypothesis: The training based on the health belief model will increase the awareness of young men in the experimental group about testicular self-examination compared to those in the control group.
H1b Hypothesis: The training based on the health belief model will increase the mean scores of the sensitivity subscale of young men in the experimental group compared to those in the control group.
H1c Hypothesis: The training based on the health belief model will increase the mean scores of the benefit subscale of young men in the experimental group compared to those in the control group.
H1d Hypothesis: The training based on the health belief model will increase the mean scores of the seriousness subscale of young men in the experimental group compared to those in the control group.
H1e Hypothesis: The training based on the health belief model will decrease the mean scores of the barriers subscale of young men in the experimental group compared to those in the control group.
H1f Hypothesis: The training based on the health belief model will increase the mean scores of the health motivation subscale of young men in the experimental group compared to those in the control group.
H1g Hypothesis: The training based on the health belief model will increase the mean scores of the self-efficacy subscale of young men in the experimental group compared to those in the control group.
Study Overview
Detailed Description
The research data will be obtained from students of Hitit University Faculty of Health Sciences, Department of Child Development, Department of Health Management, Department of Social Work, and Department of Nutrition and Dietetics between 20 November 2023 and 15 July 2024.
Pre-intervention phase: Data collection forms were applied to n=120 participants who met the inclusion criteria and accepted the study (pretest).Experimental (n=60) and control (n=60) groups were formed by drawing lots among the participants.
"Testicular Cancer Education Program Based on Health Belief Model (SİMTEKEP)," prepared by the researcher based on the literature, was carried out in four sessions. In the first session (45-60 minutes), "Male reproductive organs, testicular cancer and its symptoms (PERCEPTION OF SENSITIVITY)"; in the second session (45-60 minutes), "Treatment of testicular cancer and its negative effects (PERCEPTION OF SERIOUSNESS)"; in the third session (45-60 minutes) "Early diagnosis and Testicular Self-Examination (PERCEPTION OF BENEFIT and SELF-EFFICIENCY)"; and in the last session (45-60 minutes), "Testicular Self-Examination (PERCEPTION OF OBSTACLE)" topics were discussed. After the training, reminder messages were sent to the participants once a week.
Post-intervention phase: At the end of the third month after the intervention, data collection forms will be applied again, and the research process will be completed (Monitoring).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Corum, Turkey, 19000
- Hitit University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being male
- Being between the ages of 18 and 35
- Studying at Hitit University Faculty of Health Sciences
- Not having attended a course or training program on testicular cancer.
Exclusion Criteria:
- Being under 18 years of age or over 35 years of age
- Being a student in the Department of Nursing
- Participating in a course or training program on testicular cancer
- Having testicular cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Training group
Group receiving training based on SIMTEKEP program
|
Young men who are included in the research sample and agree to participate in the study will be given training within the scope of the health belief model.
|
|
No Intervention: Control group
The group that did not receive training based on the SIMTEKEP program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic information and testicular cancer questionnaire
Time Frame: one week
|
As a pre-test, a survey form consisting of 21 questions prepared by the researcher by scanning the literature.
|
one week
|
|
Testicular Cancer Knowledge Test
Time Frame: one week
|
As a pre-test, a knowledge test consisting of 20 questions prepared by the researcher by scanning the literature. There are true and false statements in the Testicular Cancer Knowledge Test. Participants are asked to evaluate these statements as true or false. Each correct answer is evaluated as 1 point, and an incorrect answer is evaluated as 0 points. |
one week
|
|
Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination
Time Frame: one week
|
As a pre-test, Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination The minimum score from the scale is 37 and the maximum is 185. Each dimension of the scale is evaluated separately, and as the score increases, positive behavior increases. |
one week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
For the control group, Testicular Cancer Knowledge Test
Time Frame: three months
|
The Testicular Cancer Knowledge Test was administered as a posttest.
|
three months
|
|
For the control group, Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination
Time Frame: three months
|
The Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination was administered as a posttest.
|
three months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Testicular Cancer Knowledge Test
Time Frame: three months
|
The Testicular Cancer Knowledge Test will be administered as a follow-up test.
|
three months
|
|
Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination
Time Frame: three months
|
The Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination will be administered as a follow-up test.
|
three months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Emre Keles, Hitit University
- Study Director: Birsen Altay, Ondokuz Mayıs University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCT-SBF-EK-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.